MACCARI, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 309
NA - Nord America 143
AS - Asia 79
AF - Africa 4
SA - Sud America 4
Totale 539
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 193
US - Stati Uniti d'America 140
IT - Italia 44
IE - Irlanda 25
HK - Hong Kong 22
CN - Cina 20
SE - Svezia 20
SG - Singapore 20
CH - Svizzera 10
JO - Giordania 9
FI - Finlandia 8
GB - Regno Unito 7
IN - India 6
CA - Canada 3
CI - Costa d'Avorio 3
AR - Argentina 2
BR - Brasile 2
DE - Germania 2
JP - Giappone 1
SD - Sudan 1
TW - Taiwan 1
Totale 539
Salva come PNG Salva come JPEG
Città #
Santa Clara 38
Dublin 25
Hong Kong 16
Chandler 13
Singapore 11
Bern 10
Florence 10
Ashburn 9
Altamura 8
Lawrence 8
Helsinki 6
Moscow 5
Shanghai 5
Boston 4
Kent 4
Princeton 4
Abidjan 3
Mumbai 3
New York 3
Toronto 3
Acquaviva delle Fonti 2
Beijing 2
Bremen 2
Buffalo 2
Cipolletti 2
Fairfield 2
Houston 2
Kolkata 2
Lappeenranta 2
Los Angeles 2
Lugo 2
Manchester 2
Maranello 2
Pisa 2
Rimini 2
Rome 2
Seattle 2
Southport 2
São Paulo 2
Andover 1
Ann Arbor 1
Brooklyn 1
Caronno Pertusella 1
Corato 1
Fiesole 1
Genova 1
Glasgow 1
Milan 1
New Taipei City 1
Obata 1
Poplar 1
Pune 1
Romola 1
San Diego 1
San Mateo 1
Scandicci 1
Sesto Fiorentino 1
Torquay 1
Washington 1
Wilmington 1
Xingtai 1
Yubileyny 1
Totale 249
Salva come PNG Salva come JPEG
Nome #
JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis 65
Integration of multiparameter flow cytometry score improves prognostic stratification provided by standard models in primary myelofibrosis 63
Clinical and molecular predictors of fibrotic progression in essential thrombocythemia: A multicenter study involving 1607 patients 58
Effect of age and treatment on predictive value of measurable residual disease: implications for clinical management of adult patients with acute myeloid leukemia 53
ASXL1 mutations are prognostically significant in PMF, but not MF following essential thrombocythemia or polycythemia vera 52
Increased plasma levels of lncrnas linc01268, gas5 and malat1 correlate with negative prognostic factors in myelofibrosis 52
Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: Update of the ERNEST Study 49
Phenotypic correlations of CALR mutation variant allele frequency in patients with myelofibrosis 41
CALR mutation burden in essential thrombocythemia and disease outcome 34
The prognostic contribution of CBL, NRAS, KRAS, RUNX1, and TP53 mutations to mutation-enhanced international prognostic score systems (MIPSS70/plus/plus v2.0) for primary myelofibrosis 29
Clonal dynamics and copy number variants by single-cell analysis in leukemic evolution of myeloproliferative neoplasms 27
SF3B1 mutations in primary and secondary myelofibrosis: Clinical, molecular and prognostic correlates 24
One thousand patients with essential thrombocythemia: the Florence-CRIMM experience 5
Clinical impact of mutated JAK2 allele burden reduction in polycythemia vera and essential thrombocythemia 4
Totale 556
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.309
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.309
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202223 0 0 0 0 0 0 0 13 0 1 3 6
2022/2023129 9 20 7 10 3 19 21 3 14 7 5 11
2023/2024112 5 7 8 5 18 12 1 21 4 10 10 11
2024/2025292 18 59 47 132 36 0 0 0 0 0 0 0
Totale 556